Assignee
PHARMA MAR SAU
ES·8 granted patents·4 pending applications·115 citations·filing 2003–2009
Top patents by PatentIndex Score
12 records- 0192US7683028B2Kahalalide compositionsPHARMA MAR SAU·Filed 2008·Granted Mar 23, 2010·11 cites·16 claims
- 0285US7622458B2Combination of ET-743 and a 5-fluorouracil pro-drug for cancer treatmentPHARMA MAR SAU·Filed 2004·Granted Nov 24, 2009·29 cites·26 claims
- 0384US7507708B2Antitumoral compoundsPHARMA MAR SAU·Filed 2003·Granted Mar 24, 2009·14 cites·12 claims
- 0481US7309601B2Sequences from an endosymbiont and their usesPHARMA MAR SAU·Filed 2003·Granted Dec 18, 2007·28 cites·5 claims
- 0573US7576188B2Antitumoral treatmentsPHARMA MAR SAU·Filed 2004·Granted Aug 18, 2009·11 cites·14 claims
- 0668US7323444B2Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasisPHARMA MAR SAU·Filed 2004·Granted Jan 29, 2008·12 cites·10 claims
- 0762US7396837B2Antitumoral analogs of lamellarinsPHARMA MAR SAU·Filed 2003·Granted Jul 8, 2008·5 cites·28 claims
- 0860US7521478B2Total synthesis of myriaporonesPHARMA MAR SAU·Filed 2003·Granted Apr 21, 2009·5 cites·34 claims
- 0956US2008090757A1Kahalalide Compositions for the Treatment of PsoriasisPHARMA MAR SAU·Filed 2007·Application pending·0 cites
- 1053US2009227490A1Antitumoral TreatmentsPHARMA MAR SAU·Filed 2009·Application pending·0 cites
- 1139US2007082856A1Combination therapy comprising the use of et-743 and doxorubicin for treating cancerPHARMA MAR SAU·Filed 2004·Application pending·0 cites
- 1233US2007128201A1Combined use of ecteinascidin-743 and platinum antineoplastic compoundsPHARMA MAR SAU·Filed 2004·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →